Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease

KG Tolman, V Fonseca, A Dalpiaz, MH Tan - Diabetes care, 2007 - Am Diabetes Assoc
METHODS—A Medline search without limitations of date (as of October 2005), language, or
humans was carried out by the authors. The following medical subject headings were …

The liver and lovastatin

KG Tolman - The American journal of cardiology, 2002 - Elsevier
The cholesterol-lowering agents, known as statins, have been in use for 15 years and are
among the most commonly prescribed drugs. Animal studies and premarketing clinical trials …

The therapeutic use of acetaminophen in patients with liver disease

GD Benson, RS Koff, KG Tolman - American journal of …, 2005 - journals.lww.com
Acetaminophen has been used safely and effectively for many years to manage pain and/or
fever in patients of all ages. It is commonly recommended as first-line therapy for a variety of …

Determinants of serious liver disease among patients receiving low‐dose methotrexate for rheumatoid arthritis

AM Walker, D Funch, NA Dreyer… - … : Official Journal of …, 1993 - Wiley Online Library
Objective. To assess the risk of serious liver disease in patients with rheumatoid arthritis
(RA) taking methotrexate (MTX). Methods. We surveyed members of the American College …

Liver histology in rheumatoid arthritis patients receiving long‐term methotrexate therapy. A prospective study with baseline and sequential biopsy samples

JM Kremer, RG Lee, KG Tolman - Arthritis & Rheumatism …, 1989 - Wiley Online Library
Twenty‐nine patients with active rheumatoid arthritis receiving long‐term oral weekly
methotrexate (MTX) therapy were studied to determine the extent of their hepatic …

Narrative review: hepatobiliary disease in type 2 diabetes mellitus

KG Tolman, V Fonseca, MH Tan… - Annals of internal …, 2004 - acpjournals.org
Diabetes mellitus is the fifth leading cause of death in the United States; 17 million people
are affected. Liver disease is one of the leading causes of death in persons with type 2 …

Treatment of non-alcoholic fatty liver disease

KG Tolman, AS Dalpiaz - Therapeutics and clinical risk …, 2007 - Taylor & Francis
Non-alcoholic fatty liver disease, defined as the presence of macrovascular steatosis in the
presence of less than 20 gm of alcohol ingestion per day, is the most common liver disease …

Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men

AW Meikle, NA Mazer, JF Moellmer… - The Journal of …, 1992 - academic.oup.com
None of the current or experimental androgen treatment modalities for male hypogonadism
has been reported to produce physiological concentrations or circadian variations in …

Hepatotoxicity of non-narcotic analgesics

KG Tolman - The American journal of medicine, 1998 - Elsevier
The central role of the liver in drug metabolism sets the stage for drug-related hepatotoxicity.
The incidence of hepatotoxicity associated with non-narcotic analgesics is low, but their …

Hepatotoxicity of the thiazolidinediones

KG Tolman, J Chandramouli - Clinics in Liver Disease, 2003 - liver.theclinics.com
Diabetes mellitus is the fourth leading cause of death in the United States [1], affecting an
estimated 16 million people or 7% of the population [2, 3]. The economic impact is estimated …